134 related articles for article (PubMed ID: 12943941)
1. Growth hormone and prolactin response to apomorphine in bipolar and unipolar depression.
McPherson H; Walsh A; Silverstone T
J Affect Disord; 2003 Sep; 76(1-3):121-5. PubMed ID: 12943941
[TBL] [Abstract][Full Text] [Related]
2. Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients.
Monreal JA; Duval F; Mokrani MC; Fattah S; Palao D
J Psychiatr Res; 2019 May; 112():18-22. PubMed ID: 30836201
[TBL] [Abstract][Full Text] [Related]
3. Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.
Brambilla F; Bellodi L; Perna G; Arancio C; Bertani A
Biol Psychiatry; 1997 Nov; 42(10):889-97. PubMed ID: 9359974
[TBL] [Abstract][Full Text] [Related]
4. Prolactin and growth hormone response to levodopa in affective illness.
Linkowski P; Brauman H; Mendlewicz J
Neuropsychobiology; 1983; 9(2-3):108-12. PubMed ID: 6621850
[TBL] [Abstract][Full Text] [Related]
5. Multihormonal responses to apomorphine in mental illness.
Mokrani MC; Duval F; Crocq MA; Bailey PE; Macher JP
Psychoneuroendocrinology; 1995; 20(4):365-75. PubMed ID: 8532820
[TBL] [Abstract][Full Text] [Related]
6. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
Meltzer HY; Lee MA; Jayathilake K
Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
[TBL] [Abstract][Full Text] [Related]
7. Induction of tolerance of dopaminergic responses in man.
Lal S; Thavundayil JX; Ng Ying Kin NM; Dai X; Schwartz G; Montoya A
J Neural Transm (Vienna); 2008 Aug; 115(8):1189-98. PubMed ID: 18506387
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats.
Mueller GP; Simpkins J; Meites J; Moore KE
Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression.
Duval F; Mokrani MC; Crocq MA; Bailey PE; Diep TS; Correa H; Macher JP
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):207-25. PubMed ID: 10800744
[TBL] [Abstract][Full Text] [Related]
10. Effect of some peptides on dopaminergic function in man.
Lal S; Nair NP; Isaac I; Thavundayil J; Guyda H
J Neural Transm Suppl; 1990; 29():173-81. PubMed ID: 2113567
[TBL] [Abstract][Full Text] [Related]
11. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Relation to duration of illness and depressive symptoms.
Meltzer HY; Kolakowska T; Fang VS; Fogg L; Robertson A; Lewine R; Strahilevitz M; Busch D
Arch Gen Psychiatry; 1984 May; 41(5):512-9. PubMed ID: 6721674
[TBL] [Abstract][Full Text] [Related]
13. Apomorphine induced alteration in corneofundal potentials in depression.
Demet EM; Albers L; Sokolski KN; Chicz-Demet A; Chen CC; Reist C
Prog Neuropsychopharmacol Biol Psychiatry; 1997 Jul; 21(5):775-88. PubMed ID: 9278949
[TBL] [Abstract][Full Text] [Related]
14. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP
Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
[TBL] [Abstract][Full Text] [Related]
15. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
[TBL] [Abstract][Full Text] [Related]
16. A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
Llau ME; Durrieu G; Tran MA; Senard JM; Rascol O; Montastruc JL
Clin Neuropharmacol; 1996 Oct; 19(5):420-7. PubMed ID: 8889285
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects.
Jimerson DC; Cutler NR; Post RM; Rey A; Gold PW; Brown GM; Bunney WE
Psychiatry Res; 1984 Sep; 13(1):1-12. PubMed ID: 6595680
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine-induced growth hormone response is attenuated by ethanol but not dextromethorphan.
Budde H; Zimmermann US; Steffin B; Rommelspacher H; Schmidt LG; Smolka MN
Alcohol Clin Exp Res; 2007 Jan; 31(1):100-3. PubMed ID: 17207107
[TBL] [Abstract][Full Text] [Related]
19. Effects of (+/-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans.
Gerra G; Zaimovic A; Moi G; Giusti F; Gardini S; Delsignore R; Laviola G; Macchia T; Brambilla F
Behav Brain Res; 2002 Aug; 134(1-2):403-10. PubMed ID: 12191827
[TBL] [Abstract][Full Text] [Related]
20. TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders.
Agren H; Wide L
Acta Psychiatr Scand; 1986 May; 73(5):549-58. PubMed ID: 3092581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
